The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1739-1744
Author(s):
Christopher S. Navara
SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1745-1756
Author(s):
A. Y. Tsygankov and S. K. Shore
Therapeutic Potential of Inhibiting Brutons Tyrosine Kinase, (BTK)
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1757-1766
Author(s):
A. O. Vassilev and F. M. Uckun
Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1767-1784
Author(s):
M. Cetkovic-Cvrlje and H. E. Tibbles
Antimicrobial and Chemopreventive Properties of Herbs and Spices
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
1451-1460
Author(s):
P. K. Lai and J. Roy
Novel Approaches for Targeted Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
313-326
Author(s):
Veronique Guillemard and H. Uri Saragovi
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
327-336
Author(s):
Daniel Sliva
Functional Antagonism between NF-κB and Nuclear Receptors: Implications in Carcinogenesis and Strategies for Optimal Cancer Chemopreventive Interventions
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
337-344
Author(s):
V. B. Andela
Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
345-354
Author(s):
Jian Yu Rao and Ning Li
Vitamin E Analogues: A New Class of Inducers of Apoptosis with Selective Anti-Cancer Effects
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
355-372
Author(s):
Jiri Neuzil, Marco Tomasetti, Albert S. Mellick, Renata Alleva, Brian A. Salvatore, Marc Birringer and Marc W. Fariss